FDA decision delays UCB's Neupro relaunch; Covidien announces launch of Exalgo;

@FiercePharma: Pfizer halts Sutent testing for liver cancer. Article | Follow @FiercePharma

> Belgian pharmaceutical group UCB said on Friday the U.S. relaunch of its Parkinson's patch Neupro could be delayed by two years after U.S. regulators recommended reformulation of the drug. Report

> Covidien, a leading global provider of healthcare products, today introduced EXALGO (hydromorphone HCI) Extended-Release Tablets, (CII), the only extended-release hydromorphone treatment available in the U.S. Release

> Humanitarian group Medecins Sans Frontieres (MSF) on Monday criticised draft provisions of a free-trade deal between the European Union and India, saying it would boost prices of drugs for India's poor. Story

> CPEX Pharmaceuticals Inc. shareholder Richard S. Rofe launched a tender offer to buy the company, valuing it at about $40.6 million, as he said the company's board will "remain in violent conflict" with its fiduciary duty to shareholders. Report

> Dr. Reddy's Laboratories announced today that it launched amlodipine benazepril capsules (2.5mg/10mg, 5mg/10mg, 5mg/20mg, 10mg/20mg), a bioequivalent generic version of Lotrel Capsules, in the U.S. market on April 23, 2010. Release

> Mylan Pharmaceuticals Inc. has begun to market Methamphetamine Hydrochloride Tablets USP, 5 mg, based on an agreement with licensing partner Coastal Pharmaceuticals. Release

> Drug development company D-Pharm Ltd. is examining various alternatives for raising NIS 23 million. The company plans to use the proceeds to expand the development of its products, including DP-VPA, a treatment for migraines, manic depression and epilepsy. Report

Biotech News

 @FierceBiotech: Vatican backs adult stem cell research with $2.7M. Article | Follow @FierceBiotech 

 @JohnCFierce: Contract research in China booming at a rate of 30% a year. Report | Follow @JohnCFierce

> China's growing appeal to the global CRO industry. Story

> Biotech watchers on high alert for Provenge decision. Item

> Marshall Edwards names experienced biotech CEO to the helm. Report

Biotech IT News

> FDA cites Pfizer for pediatric antipsychotic trial errors. Article

> Bio-Optronics system augments site CTMS. Report

> CRO Target Health upgrades electronic document system. Story

> Carestream taps KIKA EDC/Clinical Asset Management. Item

And Finally... South Africa is in the midst of a feverish buildup of HIV testing, treatment and prevention that United Nations officials say is the largest and fastest expansion of AIDS services ever attempted by any nation. Report